ASCO 2018

A phase 3 trial of sunitinib alone versus nephrectomy followed by sunitinib in patients with intermediate- and poor-risk metastatic renal cell carcinoma (RCC) suggests surgery may not always be necessary. The CARMENA trial presented at the ASCO 2018 meeting and published...

A phase 3 trial of sunitinib alone versus nephrectomy followed by sunitinib in patients with intermediate- and poor-risk metastatic renal...

A new standard of care is on the horizon for advanced cutaneous squamous cell carcinoma (SCC), a leading Australian medical oncologist has told the ASCO meeting in Chicago. Professor Danny Rischin, Director of the Division of Cancer Medicine and Head of...

A new standard of care is on the horizon for advanced cutaneous squamous cell carcinoma (SCC), a leading Australian medical...

Up to 85% of women with early ER-positive, HER2-negative, node-negative breast cancer can be spared chemotherapy, according to results presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. The TAILORx trial of more than 10,000 women found endocrine...

Up to 85% of women with early ER-positive, HER2-negative, node-negative breast cancer can be spared chemotherapy, according to results presented...